In this free webinar, gain insights into technologies and regulatory implications for inhaled biologics. The featured speaker will share device, drug delivery, formulation and other technical considerations when developing inhaled biologics.
TORONTO, Nov. 30, 2023 /PRNewswire-PRWeb/ -- Discover an innovative webinar to explore the potential of inhaled biologics, with insights on formulation, analysis and regulatory considerations. While inhalation and biologics have been combined in notable ways such as insulin and dornase alfa, it has not been popularized broadly as a category. If inhalation is going to successfully combine with biologics, what current knowledge of formulating, analyzing and manufacturing inhaled small molecules will be useful and what other areas of expertise are needed?
This presentation will discuss how small molecule techniques can be applied to large molecules and where the current approach to biologics needs to be changed.
This webinar will delve into:
Register for this webinar and delve into the synergy of inhaled biologics, gaining key insights into regulatory implications, formulation technologies and analytical techniques and paving the way for groundbreaking advancements.
For more information, or to register for this event, visit Inhaled Biologics: Formulation, Analysis and Regulation.
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars and digital content to the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps professionals stay current with industry developments, regulations and jobs. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.